Drug recall · November 26, 2025
DermaSarra recall
Why: CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
DermaSarra, Camphor 0.5%, External Analgesic, 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-189-08
- Lots / codes
All lots on or before expiry date 08/2027
- Quantity
- 2,389 bottles
- Company
- DermaRite Industries, LLC, North Bergen, NJ
- Distribution
- Nationwide in the USA
- Initiated
- August 27, 2025 · Voluntary: Firm initiated
- Classified
- November 20, 2025
- Reported
- November 26, 2025
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Camphor
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.